index.php
 

Index • Roche Media News

Link: Roche Media News

    The latest media news from Roche
  1  2  3  4  5  6  7  8  9  10  next

Roche today announced that the U.S. Food and Drug Administration (FDA) approved Avastin #174; (bevac ... more

Roche today announced that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance ... more

Today Roche presented development plans for its Basel site. Over the next 10 years, Roche will inves ... more

Roche today announced that the U.S. Food and Drug Administration (FDA) has approved Esbriet (pirfeni ... more

Group sales up 5% at CER, stable in Swiss francs; 4% higher sales in Pharmaceuticals Division, with ... more

Roche today announced positive data from the coBRIM Phase III study. The results showed that people ... more

Roche today announced final survival results from the Phase III CLEOPATRA study, which showed that a ... more

Roche announced today the launch of a new Global Access Program for HIV viral load testing, created ... more

Roche announced today that RoACTEMRA (tocilizumab) has received approval from the European Commissio ... more

Data from the coBRIM study will be presented at an upcoming medical meeting. Roche plans to submit t ... more

The U.S. Food and Drug Administration (FDA) has granted first Breakthrough Therapy Designation in bl ... more

Roche announced today that the subcutaneous formulation of RoACTEMRA (tocilizumab) has received appr ... more

Roche announced today that the U.S. Food and Drug Administration (FDA) approved the cobas HPV (Human ... more

Roche announced today that the European Commission (EC) has approved a new subcutaneous (SC) formula ... more

Roche today announced that the U.S. Food and Drug Administration (FDA) approved Xolair (omalizumab) ... more

Roche announced today that the U.S. Food and Drug Administration (FDA) Microbiology Devices Panel of ... more

Diagnostics division strengthens its position in the serology market and expands its immunoassay por ... more

New data show lebrikizumab appears most effective in a specific sub-population of patients with high ... more

Roche announced today the launch of the fully automated CINtec PLUS cytology test to improve the det ... more

Roche announced today that the EU Committee for Medicinal Products for Human Use (CHMP) recommended ... more

Roche announced today that the subcutaneous formulation of RoACTEMRA (tocilizumab) has received a po ... more

Roche today announced that the U.S. Food and Drug Administration (FDA) approved Gazyva (obinutuzumab ... more

Roche today announced that the U.S. Food and Drug Administration (FDA) has approved a subcutaneous f ... more

Investment to help meet rising demand for licensed biologics and expected pipeline growth. ... more

Roche inaugurates Translational and Clinical Research Center at the Alexandria Center for Life Scien ... more

Roche today announced that the United States (U.S.) Food and Drug Administration (FDA) granted accel ... more

- New injectable administration takes two to five minutes, rather than 30 to 90 minutes with the cur ... more

Roche and Ascletis announced today that they have entered into a collaboration to develop and commer ... more

Roche announced today that the European Union #8217;s Committee for Medicinal Products for Human Use ... more

Roche, today announced that the Committee for Medicinal Products for Human Use (CHMP) has recommende ... more

Roche announced today the acquisition of PVT Probenverteiltechnik GmbH based in Waiblingen, Germany ... more

Roche announced today that STAGE, a Phase III trial evaluating ocrelizumab as a treatment for seropo ... more

Roche announced the winners of its global 3Rs Award Program - a unique and innovative program that h ... more

New data presented today showed that, for the first time, doctors can predict which hepatitis B pati ... more

Genentech, Inc. (NYSE: DNA), GlycArt, a company wholly-owned by Roche, and Roche (SWX: ROG) have ent ... more

Roche today announced that the U.S. Food and Drug Administration (FDA) has issued a complete respons ... more

Roche announced today that the European Commission has approved a shortened, 16-week course of treat ... more

  1  2  3  4  5  6  7  8  9  10  next